Skip to main content

Table 1 Baseline characteristics

From: Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial

 

Placebo

Etoricoxib 90 mg 

Etoricoxib 120 mg

Ibuprofen 1800 mg

 

N = 98

N = 224

N = 230

N = 224

Female n (%)

56 (57.1)

134 (59.8)

139 (60.4)

152 (67.9)

Age

    

Mean [yr (SD)]

65.2 (7.9)

65.7 (8.5)

64.7 (8.1)

66.0 (8.1)

Median

64.5

66.0

64.0

66.0

Range

43 - 81

37 - 84

44 - 86

38 – 84

Height in cm (SD)

167.1 (10.6)

166.9 (10.8)

168.1 (10.6)

165.8 (10.6)

Body Weight in kg (SD)

85.9 (17.3)

86.2 (17.6)

85.4 (16.2)

84.4 (16.6)

Body Mass Index (SD)

30.6 (4.7)

30.8 (5.0)

30.2 (4.7)

30.6 (4.7)

Duration of Surgery in hours (SD)

1.4 (0.5)

1.4 (0.5)

1.4 (0.5)

1.4 (0.5)

Baseline Pain Intensity at Rest NRS (SD)

    

Mean Score (SD)

7.1 (1.8)

7.0 (1.8)

7.1 (1.8)

6.9 (1.7)

Mild Pain (Score: 0–4) n (%)

0 (0.0)

1 (0.4)

0 (0.0)

1 (0.4)

Moderate Pain (Score 5–7) n (%)

60 (61.2)

137 (61.2)

135 (58.7)

140 (62.2)

Severe Pain (Score 8–10) n (%)

38 (38.8)

85 (37.9)

94 (40.9)

83 (37.1)

Anesthesia Type n (%)

    

 General

38 (38.8)

83 (37.1)

90 (39.1)

81 (36.2)

 Spinal

60 (61.2)

141 (62.9)

140 (60.9)

142 (63.4)

 Other

0 (0.0)

0 (0.0)

0 (0.0)

1 (0.4)